These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9371239)

  • 21. GnRH analogues--agonists and antagonists.
    Padula AM
    Anim Reprod Sci; 2005 Aug; 88(1-2):115-26. PubMed ID: 15955640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Struthers RS; Porter J; Lahrichi SL; Jiang G; Cervini LA; Ibea M; Kirby DA; Koerber SC; Rivier CL
    J Med Chem; 2000 Mar; 43(5):784-96. PubMed ID: 10715147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiovulatory antagonists of LHRH related to antide.
    Flouret G; Arnold ZS; Majewski T; Petousis NH; Mahan K; Farooqui F; Blum KA; Konopinska D; Natarajan S; Crich D
    J Pept Sci; 1995; 1(2):89-108. PubMed ID: 9222987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioligand assay for gonadotropin-releasing hormone: relative potencies of agonists and antagonists.
    Perrin MH; Rivier JE; Vale WW
    Endocrinology; 1980 Apr; 106(4):1289-96. PubMed ID: 6987053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro.
    Rivier JE; Porter J; Rivier CL; Perrin M; Corrigan A; Hook WA; Siraganian RP; Vale WW
    J Med Chem; 1986 Oct; 29(10):1846-51. PubMed ID: 2428978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse model of male germ cell apoptosis in response to a lack of hormonal stimulation.
    Hikim AP; Vera Y; Elhag RI; Lue Y; Cui YG; Pope V; Leung A; Atienza V; Wang C; Swerdloff RS
    Indian J Exp Biol; 2005 Nov; 43(11):1048-57. PubMed ID: 16315394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of biologically active, conformationally constrained GnRH antagonists.
    Struthers RS; Tanaka G; Koerber SC; Solmajer T; Baniak EL; Gierasch LM; Vale W; Rivier J; Hagler AT
    Proteins; 1990; 8(4):295-304. PubMed ID: 2091022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
    Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
    J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone.
    Hild SA; Attardi BJ; Reel JR
    Biol Reprod; 2004 Jul; 71(1):348-58. PubMed ID: 15044265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Jiang G; Struthers RS; Koerber SC; Porter J; Cervini LA; Kirby DA; Craig AG; Rivier CL
    J Med Chem; 2000 Mar; 43(5):807-18. PubMed ID: 10715149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.
    Miranda A; Lahrichi SL; Gulyas J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W; Rivier J
    J Med Chem; 1997 Oct; 40(22):3651-8. PubMed ID: 9357532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
    Rivier J; Gulyas J; Corrigan A; Martinez V; Craig AG; Taché Y; Vale W; Rivier C
    J Med Chem; 1998 Dec; 41(25):5012-9. PubMed ID: 9836619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
    Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
    J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of GnRH antagonists vs agonists in domestic carnivores, a review.
    Gobello C
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():373-6. PubMed ID: 23279542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties.
    Rivier J; Theobald P; Porter J; Perrin M; Gunnet J; Hahn DW; Rivier C
    Biochem Biophys Res Commun; 1991 Apr; 176(1):406-12. PubMed ID: 1850267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA recommendations for preclinical testing of gonadotropin releasing hormone (GnRH) analogues.
    Raheja KL; Jordan A
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):168-75. PubMed ID: 8041914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 May; 12(5):347-53. PubMed ID: 16285023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.
    Rivier JE; Kirby DA; Lahrichi SL; Corrigan A; Vale WW; Rivier CL
    J Med Chem; 1999 Aug; 42(16):3175-82. PubMed ID: 10447963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.